Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centocor IncfiledCriticalCentocor Inc
Priority to UY29552ApriorityCriticalpatent/UY29552A1/en
Publication of UY29552A1publicationCriticalpatent/UY29552A1/en
La presente invención se refiere a un nuevo anticuerpo anti-MCP-1, que incluye ácidos nucleicos aislados que codifican por lo menos un anticuerpo antiMCP-1, MCP-1, vectores, células huésped, animales o plantas transgénicas, y métodos para preparar y usar a estos, que incluyen composiciones, métodos y dispositivos terapéuticos.The present invention relates to a novel anti-MCP-1 antibody, which includes isolated nucleic acids encoding at least one antiMCP-1 antibody, MCP-1, vectors, host cells, transgenic animals or plants, and methods for preparing and use these, which include compositions, methods and therapeutic devices.
UY29552A2006-05-192006-05-19
ANTI-MCP-1 ANTIBODIES, COMPOSITIONS, METHODS AND USES
UY29552A1
(en)
Isolated bivalent antibody or bivalent fragment thereof, which acts on lrp6 enhancing a wnt signal by grouping one or more lrp6 receptors in the presence of a lrp6 binding protein; nucleic acid encoding it; vector comprising said nucleic acid; pharmaceutical composition comprising a multivalent anti-lrp6 antibody; and its use to treat cancer.
Polynucleotide encoding modified oleosin including at least one artificially introduced cysteine, genetic construct comprising said polynucleotide; host cell; composition comprising an oily body; animal food that comprises the oily body.